Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress
REDWOOD CITY, Calif., Aug 4 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX ) today reported financial results and business progress for the quarter ended June 30, 2009. Total revenue increased to $36.6 million in the second quarter of 2009 compared w...International Milk Genomics & Human Health Symposium Speaker Program Announced
The speaker program for the 6th International Symposium on Milk Genomics & Human Health has been released. The three-day event will be held September 28-29, 2009 at the Mercure Paris Porte de Versailles Expo Hotel in Paris, France. The agenda for the 6th annual meeting includes presentations ...Cardinal Health Completes Biotech Acquisition
DUBLIN, Ohio, Aug. 3 /PRNewswire-FirstCall/ -- Cardinal Health today announced it has agreed to acquire the assets of privately held Biotech, an operator of Positron Emission Tomography (PET) cyclotrons and nuclear pharmacies in the Southwestern United States. Cardinal Health...Digitas Health Expands Adding Two Key Locations
PHILADELPHIA, July 27 /PRNewswire/ -- Digitas Health, Medical Marketing & Media magazine's 2009 Agency of the Year, today announces the opening of two key new locations in London and Boston. This move is a strategic part of the agency's 2010 growth plan. Digitas Health has ...Anthony Hess to Lead SAIC Health Solutions Business Unit
SAN DIEGO and MCLEAN, Va., July 16 /PRNewswire-FirstCall/ -- Science Applications International Corporation (NYSE: SAI ) announced today that Anthony Hess, Ph.D., will be appointed as business unit (BU) general manager of SAIC's Health Solutions BU (HSBU) effective Aug. 3. Hess ...BIO Ventures for Global Health Announces Management Changes
Christopher D. Earl Resigning as CEO Board member Melinda Moree named interim leader WASHINGTON, June 25 /PRNewswire-USNewswire/ -- BIO Ventures for Global Health (BVGH) today announced that Christopher D. Earl, Ph.D., will resign from BVGH, effective July 9, 2009. Melinda Moree, Ph.D., ...SyntheMed Receives Frost & Sullivan Health Innovation Award Nomination
ISELIN, N.J., June 23 /PRNewswire-FirstCall/ -- SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion products, announced today that the company was recently nominated for the prestigious Frost & Sullivan Health Inn...Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August
Advisory Committee to Review Denosumab Data THOUSAND OAKS, Calif., June 22 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN ) today announced that the U.S. Food and Drug Administration (FDA) has asked the company to participate in a meeting of the Reproductive Health Drugs Advisory Commi...GeoVax Signs HIV/AIDS Vaccine Proposal With Health and Hospital System of Cook County, Illinois
ATLANTA, June 18 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based biopharmaceutical company developing human vaccines for diseases caused by the HIV-1 (Human Immunodeficiency Virus), and other infectious agents, announced today that it signed a proposal to...Pharmaceutical Institute Launches New E-Course Focused on Health Policy
RALEIGH, N.C., June 17 /PRNewswire/ -- Pharmaceutical Institute (PI), a leading provider of specialized training solutions for the pharmaceutical and biotech industry, today announced the release of a new e-course titled, Introduction to Health Policy . The course is the newest addition to the c...National Institutes of Health Join Nation's Leading Postgrad Bio Jobs Board
SANTA CRUZ, Calif., June 16 /PRNewswire/ -- Six prestigious members of the National Institutes of Health have joined Bio Career Center ( www.BioCareerCenter.com ), the nation's leading online jobs board and careers site for life science professionals. The NIH has the highest number of post-...Insmed CEO Resigns Due to Health Concerns
- Melvin Sharoky, M.D. to Assume the Role of Chairman of the Board - RICHMOND, Va., June 15 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM ), a biopharmaceutical company, today announced that Geoffrey Allan, Ph.D. has resigned as Insmed's President, Chief Executive Officer and Chairman...Video: Varicose Veins, Much More Than a Cosmetic Issue, Can Prove a Health Risk
Left Untreated, They May Enlarge and Worsen Over Time CHICAGO, June 15 /PRNewswire/ -- Many Latinas who suffer from varicose veins often dismiss the enlarged leg veins as a cosmetic issue without recognizing they can lead to pain and discomfort. As many women often postpone visiting their doc...Kuvan Receives Priority Review Status From Health Canada
NOVATO, Calif., June 10 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) announced today that it has received notice of priority review status for Kuvan(R) (sapropterin dihydrochloride) as an oral treatment for patients with phenylketonuria (PKU) from Health Canada. Priori...Providence Health & Services Increases Revenue by $35 Million Using Concuity ClearContracts
Providence expands use of Concuity products across 16 facilities following success to date increasing net revenue VERNON HILLS, Ill., June 8 /PRNewswire-FirstCall/ -- Concuity, A Healthcare Division of Trintech, Inc. (Nasdaq: TTPA ) announced today that Providence Health & Service...Optimal Reading Services Group, Inc. Receives Investment from Health Evolution Partners
Investment Positions Optimal for Expansion in Medical Imaging Management For Hospitals, Clinics and Radiology Groups BIRMINGHAM, Ala., June 4 /PRNewswire/ -- Optimal Reading Services Group, Inc., a US-based, leading provider of medical imaging optimization services for hospitals, imaging c...Ganeden Biotech, Liquid Health Labs Unveil New Drink Technology
New PowerCap(R) Water Bottle Dispenses Probiotics with a Push of a Button CLEVELAND, June 4 /PRNewswire/ -- Ganeden Biotech, Inc ., makers of the patented probiotic strain Ganeden BC30 (R), today announced a collaboration with Liquid Health Labs to sell a new probiotic-enhanced beverage us...Amylin Pharmaceuticals to Present at Goldman Sachs Annual Global Health Care Conference
SAN DIEGO, June 3 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) will be presenting at the Goldman Sachs Annual Global Health Care Conference on Tuesday, June 9, 2009 at 10:45 a.m. ET / 7:45 a.m. PT in New York. Daniel M. Bradbury, president and chief executive officer...Amylin Pharmaceuticals to Present at Deutsche Bank Health Care Conference
SAN DIEGO, May 12 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) will be presenting at the Deutsche Bank Health Care Conference on Tuesday, May 19, 2009 at 11:30 a.m. ET / 8:30 a.m. PT in Boston. Daniel M. Bradbury, president and chief executive officer of Amylin Pharm...Masimo to Present at the Deutsche Bank 34th Annual Health Care Conference
IRVINE, Calif., May 12 /PRNewswire-FirstCall/ -- Masimo Corporation (Nasdaq: MASI ), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, today announced that its management is scheduled to present at the Deutsche Bank 34th Annual Health Care Confere...BioMarin to Present at the Deutsche Bank Health Care Conference
NOVATO, Calif., May 12 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today announced that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will present a company update at the Deutsche Bank 34th Annual Health Care Conference in Boston on Tuesday, May 19, 2009 ...Idenix Pharmaceuticals to Present at The Deutsche Bank 2009 Health Care Conference
CAMBRIDGE, Mass., May 11 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ) announced today that Idenix management will present a corporate overview at the upcoming Deutsche Bank 2009 Health Care Conference on Monday, May 18, 2009 at 8:40 a.m. ET at the Intercontinental Hotel...Neurocrine Biosciences to Present at the Deutsche Bank 34th Annual Health Care Conference
LIVE AUDIO WEBCAST MONDAY, MAY 18, 2009 SAN DIEGO, May 11 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences will be presenting at the Deutsche Bank 34th Annual Health Car...